Brief: HBM Says Unit Enters Collaboration Agreement With Dragonfly Therapeutics
21/11/2022 10:33
Nov 21 (Reuters) - Hbm Holdings Ltd 2142.HK :
* UNIT ENTERS COLLABORATION AGREEMENT TO DISCOVER & DEVELOP
ANTIBODIES FOR BISPECIFIC/MULTISPECIFIC THERAPEUTIC ANTIBODY
GENERATION
* COLLABORATION AGREEMENT WITH DRAGONFLY THERAPEUTICS
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study